MedCity News Dexcom launches first VC fund Dexcom launched its first venture fund. The company, which makes continuous glucose monitors, plans to invest in glucose sensing technologies and metabolic monitoring. Shares1
Medical device company Dexcom is launching its first venture fund. The San Diego-based company, one of a few competing for dominance in the market for continuous glucose monitors, plans to invest in technologies related to its core business and adjacent technologies. Steve Pacelli, Dexcom’s executive vice president of strategy and corporate development, will lead Dexcom Ventures. “While we have matured as a company over the years, we still consider ourselves to be a ‘start-up’ of sorts,” he said in a news release. “We feel well positioned to invest early and support our portfolio companies as they pioneer markets.’’